Patton Fund Management’s Moderna MRNA Stock Holding History

Patton Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-88,410	Closed	-$4.49M	–	334
2026 Q1	$4.49M	Buy	88,410 +80,920	+1,080%	+$3.78M	0.76%	20
2025 Q4	$221K	Buy	+7,490	New	+$203K	0.03%	354
2025 Q3	–	Sell	-10,132	Closed	-$280K	–	497
2025 Q2	$280K	Buy	+10,132	New	+$267K	0.06%	102
2023 Q1	–	Sell	-1,155	Closed	-$207K	–	179
2022 Q4	$207K	Buy	+1,155	New	+$189K	0.06%	158
2021 Q4	–	Sell	-3,955	Closed	-$1.52M	–	101
2021 Q3	$1.52M	Buy	+3,955	New	+$1.46M	0.58%	58

Other funds holding MRNA

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

MIM

Morningstar Investment Management Chicago, Illinois $1.62B AUM 13.96% 1-Year Est. Return

LAI

Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Patton Fund Management's MRNA Position: Q2 2026 in Review

Patton Fund Management sold out of Moderna (MRNA) in Q2 2026, closing a stake of 88,410 shares — an estimated $4.49M sold.

Patton Fund Management first reported a position in MRNA in Q3 2021 and held it in 5 quarters. The position peaked at $4.49M in Q1 2026. 126 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Patton Fund Management reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
Patton Fund Management sold 88,410 Moderna shares in Q2 2026, an estimated $4.49M.
Patton Fund Management first reported a position in Moderna in Q3 2021 and held it in 5 quarters.
Patton Fund Management's Moderna position peaked at $4.49M in Q1 2026.
126 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.